J Cassidy

1.6k total citations
43 papers, 1.2k citations indexed

About

J Cassidy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, J Cassidy has authored 43 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Economics and Econometrics. Recurrent topics in J Cassidy's work include Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (19 papers) and Economic and Financial Impacts of Cancer (6 papers). J Cassidy is often cited by papers focused on Colorectal Cancer Treatments and Studies (24 papers), Cancer Treatment and Pharmacology (19 papers) and Economic and Financial Impacts of Cancer (6 papers). J Cassidy collaborates with scholars based in United Kingdom, United States and Spain. J Cassidy's co-authors include Neil Campbell, Lewis Ritchie, Julian Little, Linda Sharp, Alison M. Elliott, D. Bissett, Stan B. Kaye, Peter D. Wilson, A Setanoians and Leonard B. Saltz and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Nutrition and British Journal of Cancer.

In The Last Decade

J Cassidy

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Cassidy United Kingdom 15 918 272 139 130 112 43 1.2k
Ishwaria M. Subbiah United States 19 583 0.6× 324 1.2× 73 0.5× 118 0.9× 58 0.5× 94 1.1k
Hélène Senellart France 19 862 0.9× 379 1.4× 53 0.4× 293 2.3× 74 0.7× 78 1.2k
Eleonora Feletto Australia 17 500 0.5× 195 0.7× 94 0.7× 112 0.9× 139 1.2× 62 965
D. Dalley Australia 16 858 0.9× 398 1.5× 73 0.5× 213 1.6× 103 0.9× 35 1.5k
T.J. Wilhite United States 7 872 0.9× 432 1.6× 98 0.7× 211 1.6× 74 0.7× 15 1.3k
E. Franssen Canada 17 759 0.8× 495 1.8× 71 0.5× 287 2.2× 113 1.0× 35 1.9k
Geoff Porter Canada 14 625 0.7× 218 0.8× 77 0.6× 442 3.4× 75 0.7× 46 942
Marwan Ghosn Lebanon 19 786 0.9× 458 1.7× 52 0.4× 188 1.4× 42 0.4× 122 1.4k
Daniela Pierannunzio Italy 10 787 0.9× 364 1.3× 156 1.1× 303 2.3× 99 0.9× 18 1.6k
Lewis E. Foxhall United States 15 623 0.7× 280 1.0× 63 0.5× 165 1.3× 144 1.3× 29 1.5k

Countries citing papers authored by J Cassidy

Since Specialization
Citations

This map shows the geographic impact of J Cassidy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cassidy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cassidy more than expected).

Fields of papers citing papers by J Cassidy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Cassidy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cassidy. The network helps show where J Cassidy may publish in the future.

Co-authorship network of co-authors of J Cassidy

This figure shows the co-authorship network connecting the top 25 collaborators of J Cassidy. A scholar is included among the top collaborators of J Cassidy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Cassidy. J Cassidy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cassidy, J, et al.. (2020). Barriers to older adults seeking sexual health advice and treatment: A scoping review. International Journal of Nursing Studies. 107. 103566–103566. 62 indexed citations
2.
Chu, Eric Chun‐Pu, Daniel G. Haller, Thomas H. Cartwright, et al.. (2011). Epidemiology and natural history of central venous access device (CVAD) use and infusion pump performance among patients (pts) treated for metastatic colorectal cancer (mCRC): Analysis from the NO16966 trial.. Journal of Clinical Oncology. 29(15_suppl). e14010–e14010. 1 indexed citations
3.
Madi, Ayman, Richard Adams, Michel Seymour, et al.. (2010). THE IMPACT OF MILD RENAL IMPAIRMENT ON THE TOXICITY OF OXALIPLATIN AND FLUOROPYRIMIDINE REGIMENS: EXPERIENCE IN THE MRC COIN TRIAL. Annals of Oncology. 21. 22–22. 2 indexed citations
4.
Garrison, L., J Cassidy, MN Saleh, et al.. (2007). Cost comparison of XELOX compared to FOLFOX4 with or without bevacizumab (bev) in metastatic colorectal cancer. Journal of Clinical Oncology. 25(18_suppl). 4074–4074. 14 indexed citations
5.
Scheithauer, Werner, J Cassidy, Arié Figer, et al.. (2007). A comparison of medical resource use for 4 chemotherapy regimens as first-line treatment for metastatic colorectal cancer (MCRC): XELOX vs. FOLFOX4 ± bevacizumab (A). Journal of Clinical Oncology. 25(18_suppl). 4098–4098. 9 indexed citations
6.
Jelić, S., et al.. (2005). Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis. Cancer Chemotherapy and Pharmacology. 56(6). 594–602. 9 indexed citations
7.
Robertson, Roy, Neil Campbell, Sally A. Smith, et al.. (2004). Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. British Journal of Cancer. 90(8). 1479–1485. 88 indexed citations
8.
Sharp, Linda, Julian Little, Nigel T. Brockton, et al.. (2002). Dietary intake of folate and related micronutrients, genetic polymorphisms in MTHFR and colorectal cancer A population-based case-control study in Scotland. Journal of Nutrition. 3542. 12 indexed citations
9.
Twelves, Chris & J Cassidy. (2002). Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer?. British Journal of Cancer. 86(11). 1670–1676. 7 indexed citations
10.
Campbell, Neil, Alison M. Elliott, Linda Sharp, et al.. (2002). Impact of deprivation and rural residence on treatment of colorectal and lung cancer. British Journal of Cancer. 87(6). 585–590. 96 indexed citations
11.
McKay, Judith, Joseph Loane, Val G. Ross, et al.. (2002). c-erbB-2 is not a major factor in the development of colorectal cancer. British Journal of Cancer. 86(4). 568–573. 64 indexed citations
12.
Sharp, Linda, Julian Little, Nigel T. Brockton, et al.. (2001). Genetic polymorphisms in folate metabolism, dietary folate intake and colorectal cancer: a population-based case-control study. Journal of Epidemiology & Community Health. 55. 2 indexed citations
13.
Cassidy, J. (2001). XELODA® IN COLORECTAL CANCER. International Journal of Clinical Practice. 55(5). 326–328. 1 indexed citations
14.
Campbell, Neil, Alison M. Elliott, Linda Sharp, et al.. (2001). Rural and urban differences in stage at diagnosis of colorectal and lung cancers. British Journal of Cancer. 84(7). 910–914. 178 indexed citations
15.
Cassidy, J. (2000). REVIEW OF OXALIPLATIN: AN ACTIVE PLATINUM AGENT IN COLORECTAL CANCER. International Journal of Clinical Practice. 54(6). 399–402. 14 indexed citations
16.
Campbell, Neil, et al.. (2000). Rural factors and survival from cancer: analysis of Scottish cancer registrations. British Journal of Cancer. 82(11). 1863–1866. 132 indexed citations
17.
Campbell, Neil, Lewis Ritchie, J Cassidy, & Julian Little. (1999). Systematic review of cancer treatment programmes in remote and rural areas. British Journal of Cancer. 80(8). 1275–1280. 38 indexed citations
18.
Cassidy, J, Luc Dirix, D. Bissett, et al.. (1998). A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.. PubMed. 4(11). 2755–61. 75 indexed citations
19.
Cassidy, J. (1994). Chemotherapy administration: Doses, infusions and choice of schedule. Annals of Oncology. 5. S25–S30. 7 indexed citations
20.
Cassidy, J. (1992). Patient-focused delivery promises to reshape hospitals.. PubMed. 73(4). 20–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ishwaria M. Subbiah Breakdown of academic impact, for papers by Hélène Senellart Breakdown of academic impact, for papers by Eleonora Feletto Breakdown of academic impact, for papers by D. Dalley Breakdown of academic impact, for papers by T.J. Wilhite Breakdown of academic impact, for papers by E. Franssen Breakdown of academic impact, for papers by Geoff Porter Breakdown of academic impact, for papers by Marwan Ghosn Breakdown of academic impact, for papers by Daniela Pierannunzio Breakdown of academic impact, for papers by Lewis E. Foxhall
Rankless by CCL
2026